GET IN TOUCH
Please lodge your grievances with SEBI at https://scores.gov.in
As per PMLA Amendment, linking of Aadhaar with Demat/Trading account is mandatory. All the existing clients shall link their Aadhaar by 31st March 2018. In case the account is not linked within the aforesaid time limit, it will be blocked till Aadhaar Submission.
As per NSDL Circular No: NSDL/POLICY/2017/0022 dated 17th April 2017, all Individual and entity accounts opened from 1st July 2014 to 31st August 2015 has to submit Foreign Account Tax Compliance Act (FATCA) self-declaration (CLICK HERE TO DOWNLOAD ATTACHED FATCA) till 30th April 2017. All the Account Holders who have opened the Demat Account from the period 1st July 2014 to 31st August 2015 are informed to submit the FATCA self declaration to their nearest DP. In case self certification are not provided till 30th April 2017, the Accounts would be blocked.
As per SEBI Letter on collection of Email Ids and Bank Account Details and with Reference to NSDL Circular No: NSDL/POLICY/2017/0009 dated 28th February 2017, it has been observed that Email Ids, Bank Account Details, Mobile Number, SMS Alert of many existing clients are not linked to their Demat Accounts or updated with their latest Bank Account thereby forcing companies to issue printed cheques/warrants and non-receipt of SMS alerts to the client. It is requested to all existing Account Holders to contact their nearest DP for updation of mentioned details in their Demat Accounts.
All existing Individual Demat Account Holders are advised to submit Aadhaar number along with copy of Aadhaar Card to their nearest FSC's.
Medplus Health Services Ltd |
---|
Registered Office: 707 7th Floor 5-9-13 Saifabad, Taramandal Commercial Complex, Hyderabad - 500004, Telangana |
Phone: 91-040-6724 6724 |
Email: cs@medplusindia.com; ir@medplusindia.com |
Website: www.medplusindia.com |
Initial public offering of 17,573,342* equity shares of face value of Rs. 2 each (Equity Shares) of Medplus Health Services Limited (The Company or the Company or the Issuer) for cash at a price of Rs. 796 per equity share (including a premium of Rs. 794 per equity share) (Offer Price) aggregating to Rs. 1398.30 crores (The Offer), comprising of a fresh issue of 7,544,511 equity shares aggregating to Rs. 600.00 crores (The Fresh Issue) by the company and an offer for sale of 10,028,831 equity shares aggregating to Rs. 798.30 crores (The Offer for Sale), comprising of 7,826,626 equity shares aggregating to Rs. 623.00 crores by PI Opportunities Fund - I (Investor Selling Shareholder), 1,344,221 equity shares aggregating to Rs. 107.00 crores by S. S. Pharma LLC, 402,010 equity shares aggregating to Rs. 32.00 crores by Shore Pharma LLC, 125,628 equity shares aggregating to Rs. 10.00 crores by Natco Pharma Limited, 125,628 equity shares aggregating to Rs. 10.00 crores by Time Cap Pharma Labs Private Limited, 89,547 equity shares aggregating to Rs. 7.13 crores by A. Raghava Reddy, 53,115 equity shares aggregating to Rs. 4.23 crores by K. Prakurthi, 27,135 equity shares aggregating to Rs. 2.16 crores by Navdeep Patyal, 18,467 equity shares aggregating to Rs.1.47 crores by Sangeeta Raju, 14,974 equity shares aggregating to Rs. 1.19 crores by R. Venkat Reddy, 276 equity shares aggregating to Rs. 0.02 crores by TK Kurien, 251 equity shares aggregating to Rs. 0.02 crores by Nithya Venkataramani, 251 equity shares aggregating to Rs .0.02 crores by Atul Gupta, 251 equity shares aggregating to Rs. 0.02 crores by Manoj Jaiswal, 251 equity shares aggregating to Rs. 0.02 crores by Rahul Garg, 100 equity shares aggregating to Rs 0.008 crores by Kollengode Ramanathan Lakshminarayana and 100 equity shares aggregating to Rs.0.008 crores by Bijou Kurien (collectively, the Other Selling Shareholders and collectively with the investor selling shareholder are referred to as the Selling Shareholders) and such equity shares, the Offered Shares). The offer includes a reservation of 69,637 equity shares, aggregating up to Rs. 5.00 crores (constituting up to 0.06% of the post-offer paid-up equity share capital), for subscription by eligible employees (as defined hereinafter) (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. The company and the investor selling shareholder may, in consultation with the book running lead managers, offer a discount of 9.80 to the offer price to eligible employees bidding in the employee reservation portion ('Employee Discount). The offer and the net offer shall constitute 14.72% and 14.67%, respectively, of the post-offer paid-up equity share capital of the Company). The face value of equity shares is Rs. 2 each. The offer price is 398 times the face value of the equity shares. *Subject to finalisation of the basis of allotment. #A discount of Rs. 78 per equity share was offered to eligible employees bidding in the employee reservation portion. Bids can be made for minimum 18 equity shares and in multiples of 18 equity shares thereafter. |
Issue | Money Payable On | ||
---|---|---|---|
Opens On | Closes On | Application | Allotment |
13-Dec-2021 | 15-Dec-2021 | ₹ 796.00 | ₹ 0.00 |
Minimum Application for shares in Nos : 18 Further Multiples of : 18 | ||
---|---|---|
(₹)Cr. | Lead Managers to the Issue | |
Project Cost | 600.00 | Axis Capital Ltd |
Project Financed through Current Offer | 1,398.30 | |
Post Issue Equity Share Capital | 23.86 | |
Issue Price | ₹796.00 |
Projects |
---|
Funding Working Capital Requirements of the Material Subsidiary, Optival |
General Corporate Purposes |
Promoted By |
---|
Gangadi Madhukar Reddy |
Lone Furrow Investments Pvt Lt |
Agilemed Investments Pvt Ltd |
Listing At |
---|
BSE |
NSE |
Registrar to the Issue |
---|
KFin Techologies Ltd |
INDIAN INDICES
84,473.01 1,288.21 (1.55%)
25,703.60 287.80 (1.13%)
GLOBAL INDICES
83.95 -0.07 (-0.08%)
18,013.98 440.68 (2.51%)
18013.16 353.14(2.00%)